Australian researchers close in on malaria vaccine

July 2, 2013

Australian researchers said Tuesday they were closing in on a potential vaccine against malaria, with a study showing their treatment had protected mice against several strains of the disease.

Michael Good, from Queensland's Griffith University, said the vaccine led to naturally existing white blood cells, or T-cells, attacking the potentially deadly malaria parasite which lives in .

"A single vaccination induced profound immunity to different malaria parasite species," the study, published Tuesday in the Journal of Clinical Investigation, states.

Good said the team's research was focused on inducing the white blood cells to attack the parasite, whatever the .

"The T-cells (), when they're induced to kill malaria, can recognise proteins throughout the parasite, even internal proteins in the parasite," he told the ABC.

"So that's where we think the novel aspect is: we've been able to induce a form of which can recognise molecules in the parasite which are present in every single strain."

Good said he believed it was the first time that a vaccine had been shown to protect against more that two strains of malaria in mice.

The vaccine was expected to be cheap and easy to manufacture, he added, meaning that—if applicable to humans—it could have a significant impact in poor countries where malaria kills thousands each year.

"But we don't want to get ahead of ourselves; we want to demonstrate, first and foremost, that the vaccine is effective in humans," Good told the broadcaster.

In 2010 an estimated 219 million people were infected with the disease and some 660,000 died, most of them African children aged under five, the UN's World Health Organisation said in December.

A study published in the Lancet in February 2012 said the global death toll was more likely to be around 1.2 million a year.

More information: Cross-species malaria immunity induced by chemically attenuated parasites, J Clin Invest. doi:10.1172/JCI66634

Related Stories

Improving human immunity to malaria

August 1, 2012

The deadliest form of malaria is caused the protozoan Plasmodium falciparum. During its life-cycle in human blood, the parasite P. falciparum expresses unique proteins on the surface on infected blood cells.

Malaria's severity reset by mosquito

May 30, 2013

(Medical Xpress)—For the first time, researchers have proven that the way in which malaria is transmitted to the host affects how severe the resulting infection will be.

Researchers reveal malaria's deadly grip

June 5, 2013

Researchers at the University of Copenhagen, in collaboration with Seattle Biomedical Research Institute, the University of Oxford, NIMR Tanzania and Retrogenix LTD, have identified how malaria parasites growing inside red ...

Recommended for you

Crystal clear images uncover secrets of hormone receptors

July 31, 2015

Many hormones and neurotransmitters work by binding to receptors on a cell's exterior surface. This activates receptors causing them to twist, turn and spark chemical reactions inside cells. NIH scientists used atomic level ...

A cheaper, high-performance prosthetic knee

July 30, 2015

In the last two decades, prosthetic limb technology has grown by leaps and bounds. Today, the most advanced prostheses incorporate microprocessors that work with onboard gyroscopes, accelerometers, and hydraulics to enable ...

Flow means 'go' for proper lymph system development

July 27, 2015

The lymphatic system provides a slow flow of fluid from our organs and tissues into the bloodstream. It returns fluid and proteins that leak from blood vessels, provides passage for immune and inflammatory cells from the ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.